CTO Selection and Qualification
Choose the right testing partner and stay compliant from day one
BioBoston helps life science teams identify, qualify, and oversee CTO/CRO testing partners so your data is reliable, your timelines stay on track, and your program stands up to FDA/EMA scrutiny.
- Senior QA/RA and GLP expertise
- CTO qualification audits and oversight
- Supports pharma, biotech, and medical devices
- On-site or remote, globally
Who this is for
This service is a fit if
- You need a new CTO/CRO for method development, testing, or specialty assays
- You’re moving fast toward IND/IDE/BLA/510(k) and can’t risk weak data
- You’ve had delays, quality issues, or poor communication with vendors before
- You need GLP expectations met and documented evidence ready for regulators
- You want stronger oversight without adding internal headcount
What you’ll get
- You will receive a clear, regulator-friendly vendor package:
- Shortlist of qualified CTO/CRO candidates that match your testing scope
- Selection criteria and decision matrix (so the choice is defensible)
- CTO qualification plan aligned to risk and regulatory expectations
- Audit report and gap remediation recommendations (if needed)
- Contract/SOW support to lock in deliverables, timelines, and quality expectations
- Ongoing vendor oversight option (monthly check-ins, KPI tracking, issue escalation)
What we do
Our CTO Selection & Qualification support can include:
- CTO/CRO identification and screening
- Scope definition for testing needs (general + specialized bioassays)
- Qualification audits (QMS, data integrity, GLP readiness, technical processes)
- Risk assessment and mitigation plan (quality, timelines, compliance)
- Contract and quality agreement support (deliverables, acceptance criteria, change control)
- Performance monitoring throughout the project (KPIs, deviations, escalation pathway)
- CAPA support if issues arise (root cause, corrective actions, effectiveness checks)
Why BioBoston
- A testing partner is only “good” if regulators trust the data
- We combine technical testing knowledge with QA/RA rigor so selection is not just “best price” or “fastest start.”
- We help you prevent the common failure modes: unclear scope, weak oversight, documentation gaps, and “surprises” late in the program
- We don’t stop at selection. We can stay engaged to keep your CTO/CRO accountable
- Recent examples of how we help:
- Helped a clinical-stage biotech replace an underperforming testing partner by running a structured selection process, qualifying the new CTO, and stabilizing delivery with clear KPIs and oversight
Supported a sponsor preparing for a key regulatory milestone by ensuring vendor documentation, data integrity practices, and quality agreements were aligned and audit-ready
Shortlist + qualification plan
We identify candidates and propose the right qualification approach (audit depth based on risk)
Select + control the partnership
We support contracting, launch governance, and optional ongoing oversight so the vendor stays on time and compliant
30-minute discovery call
We confirm your product type, testing scope, timeline, and risk level
How it works
Frequently Asked Questions
Do you work with both GLP and non-GLP testing?
Yes. We align the qualification approach to your program stage and regulatory needs.
Can you help if we already picked a CTO but want to qualify them?
Yes. We can perform a qualification audit and gap assessment and help close findings.
Do you stay involved after selection?
Yes. Many clients retain us for ongoing oversight to prevent delays, quality drift, and compliance issues.